info@sami-sabinsagroup.com +91 80 2839 7973 - 75 Careers
Sami-Sabinsa Group | Formerly Sami Labs Limited -
  • Home
  • About Us
    • Our Story
    • Our People
    • Milestones
    • Manufacturing Facilities
    • Research & Development
    • Intellectual Properties
    • Associated Companies
    • Awards
  • Products & Services
    • Nutraceutical Ingredients
    • Standardized Phyto Extracts
    • Beverage/Liquid Dietary Ingredients
    • GRAS Affirmed Products
    • Minerals for Nutritional Use
    • Multi-enzyme Blends
    • Natural Protein
    • Nutritional Fine Chemicals
    • Nutritional Ingredient Blends
    • Prebiotics, Probiotics & Synbiotics
    • Super Critical Fluid (SCF) Extracts
    • Specialty Chemicals
    • Cosmeceutical Ingredients
    • Natural Actives
    • Anti-glycation
    • Dermaceuticals
    • Nutricosmetics
    • Probiotics & Postbiotics
    • Specialty Chemicals
    • Proprietary Cosmeceutical Blends
    • Services
    • Contract Farming
    • Contract Research
    • Pharma
    • Natural Drugs
    • Chiral Drug Intermediates
  • Newsroom
    • Announcements
    • Press Releases
    • Media Coverage
    • Ads
    • Events
    • Articles
    • White Papers
    • Visit by Dr. Kalam
    • Videos
  • CSR
  • Contact Us
  • Locations
    • USAUSA
    • AustraliaAustralia
    • CanadaCanada
    • ChinaChina
    • EuropeEurope
    • JapanJapan
    • KoreaKorea
    • PolandPoland
    • South AfricaSouth Africa

Press Releases 2017

Sabinsa’s Curcumin C3 Complex® and Aspirin Combination Researched in Groundbreaking Colorectal Cancer Study

Sabinsa’s Curcumin C3 Complex® and Aspirin Combination Researched in Groundbreaking Colorectal Cancer Study Sabinsa’s Curcumin C3 Complex® and Aspirin Combination Researched in Groundbreaking Colorectal Cancer Study

October 30, 2017

Sami-Sabinsa Group Opens 2nd Continuous Extraction Facility to Meet Demand for Curcumin C3 Complex® and Other Extracts

Sami-Sabinsa Group Opens 2nd Continuous Extraction Facility to Meet Demand for Curcumin C3 Complex® and Other Extracts Sami-Sabinsa Group Opens 2nd Continuous Extraction Facility to Meet Demand for Curcumin C3 Complex® and Other Extracts

October 10, 2017

Sabinsa to Launch Promond™ Almond Protein Powder, Give Away New BioPerine® Book at Supplyside West

Sabinsa to Launch Promond™ Almond Protein Powder, Give Away New BioPerine® Book at Supplyside West Sabinsa to Launch Promond™ Almond Protein Powder, Give Away New BioPerine® Book at Supplyside West

September 22, 2017

Sabinsa Granted US Patent for Synbiotic Composition of LactoSpore® Shelf Stable Probiotic and Cranberry Fibers

Sabinsa Granted US Patent for Synbiotic Composition of LactoSpore® Shelf Stable Probiotic and Cranberry Fibers Sabinsa Granted US Patent for Synbiotic Composition of LactoSpore® Shelf Stable Probiotic and Cranberry Fibers

September 14, 2017

New Patents Granted to Sabinsa’s Cosmetics Division in US and EU

New Patents Granted to Sabinsa’s Cosmetics Division in US and EU New Patents Granted to Sabinsa’s Cosmetics Division in US and EU

July 31, 2017

Sabinsa Publishes Scientific Compendium on BioPerine® Black Pepper Extract

Sabinsa Publishes Scientific Compendium on BioPerine® Black Pepper Extract Sabinsa Publishes Scientific Compendium on BioPerine® Black Pepper Extract

July 17, 2017
  • Prev
  • 1
  • 2
  • 3
  • Next

Latest Press Release

  • New Research Published on Sami-Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient New Research Published on Sami-Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient Date: January 25, 2021
    ( 0 Votes ) 
  • Sami-Sabinsa Top Scientist Gives Presentation to U.S. FDA Sami-Sabinsa Top Scientist Gives Presentation to U.S. FDA Date: January 21, 2021
    ( 0 Votes ) 
  • Sami-Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM Sami-Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM Date: December 22, 2020
    ( 0 Votes ) 
  • Sami-Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study Sami-Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study Date: December 17, 2020
    ( 1 Vote ) 
  • Sami-Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement Sami-Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement Date: December 7, 2020
    ( 0 Votes ) 

Other Press Release

  • Press Release 2020
  • Press Release 2019
  • Press Release 2018
  • Press Release 2017
  • Press Release 2016
  • Press Release 2015
  • Press Release 2014
  • Press Release 2013
  • Press Release 2012
  • Press Release 2011
  • Press Release 2010
  • Press Release 2009
  • Press Release 2008
  • Press Release 2007
  • Press Release 2006
  • Press Release 2005
  • Press Release 2004
  • Press Release 2003
  • Press Release 2002
  • Press Release 2001
  • Press Release 2000
  • Press Release 1999
  • Press Release 1998
  • Press Release 1997
  • Press Release 1996
  • Press Release 1995

About

Founded by Dr. Muhammed Majeed, an internationally acclaimed scientist, entrepreneur and pioneer in the field of evidence-based natural ingredients, Sami-Sabinsa Group is a research-oriented multinational health science company.

Certificates

burea-veritas-certified dsir-certified ficci-certified fsrn-certified fssc-certified health-canada-certified halal-certified kosher-certified usp-certified

Global Contacts List

Australia Korea
Brasil Poland
Canada South Africa
China New Jersey, USA
Germany Utah, USA
Japan Vietnam

Get in Touch

19/1 & 19/2
Ⅰ Main, Ⅱ Phase
Peenya Industrial Area
Bangalore 560058, India
info@sami-sabinsagroup.com
+91 80 2839 7973 - 75
+91 80 2837 3035

© 2021 Sami-Sabinsa Group. All Rights Reserved.

Scroll to Top
Powered by Edkal Technologies | Privacy Policy | Terms of Use | Sitemap | Disclaimer
Disclaimer

US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.

We use cookies to ensure that we give you the best experience on our website. For more details visit our Privacy Policy
I accept